Abstract: Compositions comprising mevalonolactone, mevalonic add, mevalonate, salts of mevalonic acid, mevalonolactone monohydrate, or any combination thereof and methods of use are provided for topical application for skin care, skin supplement, hair care, and oral care. More specifically, the present disclosure is directed towards compositions comprising mevalonolactone, mevalonic acid, mevalonate, salts of mevalonic acid, mevalonolactone monohydrate, or any combination thereof for providing a skin care benefit and/or multiple skin care benefits.

Abstract: This specification relates to a process for preparing a purified human milk oligosaccharide (“HMO”) from an HMO-containing solution (e.g., a fermentation broth) by a process comprising removal of an antifoam agent, and a product of such a process.

Abstract: Compositions and methods are provided for producing crystalline forms of organic acids or salts or lactones thereof from an aqueous solution. More specifically, methods are provided for producing a crystalline form of a salt of mevalonic acid (also referred to as X-MVA) from an aqueous solution, comprising subjecting the aqueous solution comprising said X-MVA to a purification step to produce a purified solution and crystallizing said X-MVA from said purified solution by water solvent crystallization. Methods are also provided for producing mevalonolactone from an aqueous solution comprising X-MVA, comprising subjecting the aqueous solution comprising said X-MVA to cation exchange thereby converting said aqueous solution comprising X-MVA to an aqueous solution comprising mevalonolactone (MVL). Methods are also provided for producing mevalonolactone monohydrate crystals.

Abstract: Disclosed herein are aqueous compositions comprising fructose and methods of production thereof. A method for producing an aqueous composition comprising fructose can comprise, for example, conducting an enzymatic reaction by contacting water, sucrose, and a glucosyltransferase enzyme that synthesizes poly alpha-1,3-glucan having at least 30% alpha-1,3-linkages. A soluble fraction produced by such a reaction comprises at least about 55% fructose on a dry weight basis, and can be separated from insoluble poly alpha-1,3-glucan product(s), thereby providing an aqueous composition comprising fructose.

Abstract: This specification relates to preparing a purified human milk oligosaccharide (HMO) from an HMO solution by a process comprising nanofiltration, as well as processes for making foods, dietary supplements, medicines and infant formulas comprising a purified HMO. This specification also relates to purified HMOs and foods, dietary supplements, medicines and infant formulas prepared by processes disclosed in this specification.

Abstract: This specification relates to a process for preparing fucose from a human milk oligosaccharide (“HMO”) comprising a fucose moiety, as well as L-fucose compositions prepared by such a process.

Abstract: Disclosed herein are aqueous compositions comprising fructose and methods of production thereof. A method for producing an aqueous composition comprising fructose can comprise, for example, conducting an enzymatic reaction by contacting water, sucrose, and a glucosyltransferase enzyme that synthesizes poly alpha-1,3-glucan having at least 30% alpha-1,3-linkages. A soluble fraction produced by such a reaction comprises at least about 55% fructose on a dry weight basis, and can be separated from insoluble poly alpha-1,3-glucan product(s), thereby providing an aqueous composition comprising fructose.

Abstract: Disclosed herein are aqueous compositions comprising fructose and methods of production thereof. A method for producing an aqueous composition comprising fructose can comprise, for example, conducting an enzymatic reaction by contacting water, sucrose, and a glucosyltransferase enzyme that synthesizes poly alpha-1,3-glucan having at least 30% alpha-1,3-linkages. A soluble fraction produced by such a reaction comprises at least about 55% fructose on a dry weight basis, and can be separated from insoluble poly alpha-1,3-glucan product(s), thereby providing an aqueous composition comprising fructose.

Abstract: Disclosed herein are aqueous compositions comprising fructose and methods of production thereof. A method for producing an aqueous composition comprising fructose can comprise, for example, conducting an enzymatic reaction by contacting water, sucrose, and a glucosyltransferase enzyme that synthesizes poly alpha-1,3-glucan having at least 30% alpha-1,3-linkages. A soluble fraction produced by such a reaction comprises at least about 55% fructose on a dry weight basis, and can be separated from insoluble poly alpha-1,3-glucan product(s), thereby providing an aqueous composition comprising fructose.

Abstract: The invention relates to an improved nanofiltration process for separating and recovering components, such as sugars and sugar alcohols from multicomponent mixtures. The process of the invention is characterized by collecting the nanofiltration retentate/permeate in several fractions with different purity, optional recycling of at least one of the collected nanofiltration retentate/permeate fractions to the nanofiltration and recovering the desired component from the nanofiltration permeate/retentate fractions by different methods. In one embodiment of the invention, the process comprises a combination of nanofiltration and chromatography.

Abstract: A process of treating polymeric nanofiltration membranes before separation of low molecular weight compounds from a solution comprising the same by nanofiltration, wherein the treatment of the nanofiltration membranes is performed with an treatment liquid under conditions which enhance the flux of the low molecular weight compounds to the nanofiltration permeate.

Abstract: The invention relates to a nanofiltration process for enriching and concentrating a neutral organic compound into the permeated liquid with negative retention.

Abstract: A process of treating polymeric nanofiltration membranes before separation of low molecular weight compounds from a solution comprising the same by nanofiltration, characterized in that the treatment of the nanofiltration membranes is performed with an organic liquid under conditions which enhance the flux of the low molecular weight compounds to the nanofiltration permeate.

Abstract: The invention relates to an improved nanofiltration process of recovering xylose from a solution of a plant-based biomass hydrolysate. The process of the present invention is based on the regulation of the xylose flux in the nanofiltration process.

Abstract: The invention relates to an improved nanofiltration process for separating and recovering components, such as sugars and sugar alcohols from multicomponent mixtures. The process of the invention is characterized by collecting the nanofiltration retentate/permeate in several fractions with different purity, optional recycling of at least one of the collected nanofiltration retentate/permeate fractions to the nanofiltration and recovering the desired component from the nanofiltration permeate/retentate fractions by different methods. In one embodiment of the invention, the process comprises a combination of nanofiltration and chromatography.

Abstract: The invention relates to an improved nanofiltration process of recovering xylose from a solution of a plant-based biomass hydrolysate. The process of the present invention is based on the regulation of the xylose flux in the nanofiltration process.

Abstract: The invention relates to a nanofiltration process for enriching and concentrating a neutral organic compound into the permeated liquid with negative retention.

Abstract: The invention relates to removing crystallization inhibitors from a solution comprising one or more reducing sugars by nanofiltration, hydrolysis and/or chromatography. The reducing sugars are typically selected from fructose and xylose.

Abstract: The invention relates to removing crystallization inhibitors from a solution comprising one or more reducing sugars by nanofiltration, hydrolysis and/or chromatography. The reducing sugars are typically selected from fructose and xylose.

Abstract: The invention relates to removing crystallization inhibitors from a solution comprising one or more reducing sugars by nanofiltration, hydrolysis and/or chromatography. The reducing sugars are typically selected from fructose and xylose.